… levels also contribute to insulin resistance, obesity, cardiovascular … of adiponectin and its
molecular mechanisms in metabolic … Adenovirus-mediated delivery of adiponectin is reported to …

… risks of cardiovascular and kidney disease [33,34]… adiponectin results from AMPK-mediated
reduction of hepatic gluconeogenesis and increase of muscle glucose transport. Adiponectin …

… (APN), improve CVD by regulating glucose and lipid metabolism, thereby reducing … facilitating
cardiovascular homeostasis [6]. APN-mediated regulation of glucose and lipid metabolism …

… adiponectin level made it an attractive player in developing therapeutical treatments for
metabolic syndromes and cardiovascular disease. … An adiponectin receptor-mediated signaling …

… mechanisms may explain the association between higher adiponectin levels and total and
cardiovascular … Relationship of adiposity with arterial stiffness as mediated by adiponectin in …

… mediators that are thought to be associated with metabolic … low adiponectin level suggested
the possibility of adiponectin … mellitus, metabolic syndrome, or cardiovascular disease. This …

… key causative factors that mediate obesity-associated cardiovascular disorders is an urgent
and … with both cardiovascular disorders and other metabolic disorders, such as liver or kidney …

… and cardiovascular diseases associated with obesity and the metabolic syndrome. We focus
… The biosynthesis of nitric oxide (NO) is performed by AMPK and is mediated by adiponectin-…

… cardiovascular effects of adiponectin, specifically its anti-atherogenic actions and its role in
the dynamic crosstalk between AT and the cardiovascular … -mediated effects of adiponectin …

… and decreased adiponectin circulating … -metabolic risk. Additional work is required for a
better understanding of role of adipokines in the pathophysiology of MetS, cardiovascular disease…